Cited 0 time in
The first Korean case of Late-onset Vanishing White Matter Disease.
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 이영주 | - |
| dc.date.accessioned | 2021-08-03T23:19:20Z | - |
| dc.date.available | 2021-08-03T23:19:20Z | - |
| dc.date.issued | 2008-10-10 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/63786 | - |
| dc.description.abstract | Introduction: Vanishing white matter disease (VWM) is an autosomal recessive disease caused by mutations in five genes (eukaryotic translation initiation factor 2B [eIF2B] 1-5) which results in a defect in protein synthesis. Although disease onset is usually in late infancy or early childhood, the few reported adult-onset cases have been associated with mutations in R113H, E213G, and G1459A. Until now, the oldest reported person with VWM was 35 years old. Case: We report a Korean patient with adult-onset VWM who developed symptoms at 45 years of age. Her symptoms include dementia and spasticity, which have never before been reported in adult-onset VWM. Genetic analysis of her EIF2B5 gene identified a known mutation (p.Ser447Leu) as well as a novel mutation (p.Thr182Met). Discussion: This case suggests that adult-onset VWM can present with diverse clinical manifestations, which confirms that more genetic studies are needed to identify unknown genetic mutations that cause VWM. | - |
| dc.title | The first Korean case of Late-onset Vanishing White Matter Disease. | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 제27차 대한신경과 학회 학술대회 | - |
| dc.citation.conferencePlace | 부산BEXCO | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
